Drugs / AH110690
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00785759 | Sep 2008 → Mar 2009 | Alzheimer disease, amnestic disorder | GE Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AH110690 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00785759 ↗ |
| Route | Intravenous | “I.V. dose” NCT00785759 ↗ |